Clinical trial
Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood
NCT02482051 is registered in ClinicalTrials.gov with Denver Health and Hospital Authority as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood
- Lead sponsor
- Denver Health and Hospital Authority
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2015
- Completion date
- January 31, 2022
- Enrollment
- 100 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.